Researcher
Katrien Lagrou
- Disciplines:Microbiology, Public health care
Affiliations
- Department of Microbiology, Immunology and Transplantation (Department)
Responsible
From1 Aug 2020 → Today - Laboratory of Clinical Microbiology (Division)
Responsible
From1 Feb 2017 → Today - Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2003 → Today - Laboratory of Molecular Bacteriology (Rega Institute) (Division)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 17
- MucorVax – Development of a first-in-class fungal vaccine candidateFrom1 Oct 2023 → TodayFunding: IOF - technology concept exploration
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Dynamics of the Type 3 secretion system translocase(DOT3S)From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Multimodal dual-imaging-derived biomarkers for unravelling host response from lung disease progression in cystic lung fibrosis, infection and therapyFrom15 Oct 2020 → TodayFunding: FWO fellowships
- Unravelling the pathogenic mechanism behind influenza associated aspergillosisFrom25 Sep 2019 → TodayFunding: FWO fellowships
- Quantification and cross-validation of biomarkers for multi-parametric / multi-modal imaging in pre-clinical models of infectious diseasesFrom1 Sep 2019 → 23 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- IPAFLU: A prospective study assessing the incidence of invasive pulmonary aspergillosis (IPA) and identifying host and microbial risk factors predisposing to IPA among critically ill patients with severe influenzaFrom1 Dec 2018 → 30 Nov 2020Funding: BOF - various
- Posaconazole (POS) prophylaxis for the management of infuenza-associated aspergillosis (IAA) in critically ill patientsFrom1 Oct 2018 → 30 Sep 2020Funding: IOF - Industrial Research Fund
Publications
1 - 10 of 210
- The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid.(2023)
Authors: Jan Van Slambrouck, Xin Jin, Joost Wauters, Geert Molenberghs, Bart Vanaudenaerde, Robin Vos, Katrien Lagrou, Laurens Ceulemans
Pages: 114848 - Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients(2022)
Authors: Marnick Clijsters, Wout Backaert, Dirk Jochmans, Lies Laenen, Yves Debaveye, Paul De Munter, Jan Gunst, Mark Jorissen, Katrien Lagrou, Johan Neyts, et al.
Pages: 3919 - + - Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.(2021)
Authors: Lore Vanderbeke, Pierre Van Mol, Yannick Van Herck, Frederik De Smet, Stephanie Humblet-Baron, Kim Martinod, Ingrid Arijs, Bram Boeckx, Francesca Bosisio, Michael Casaer, et al.
Pages: 4117 - 4117 - Testing of antifungal drugs for the treatment of Candida albicans biofilms using an in vivo subcutaneous rat model system
Authors: P Van Dijck, Sona Kucharikova, Isabel Spriet, J Maertens, Katrien Lagrou
Pages: 23 - 23 - Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus
Authors: Katrien Lagrou
- In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis
Authors: Sona Kucharikova, Michelle Holtappels, Patrick Van Dijck, Katrien Lagrou
Pages: 4474 - 4475 - Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus
Authors: Katrien Lagrou
Pages: S114 - S120 - A dynamic data-based model describing nephropathia epidemica in Belgium
Authors: Piet Maes, Jan Clement, Katrien Lagrou, Marc Van Ranst, Pol Coppin, Daniel Berckmans, Jean-Marie Aerts
Pages: 77 - 89 - ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013
Authors: Katrien Lagrou
Pages: 5 - 26 - Humaan bocavirus: een nieuwe verwekker van respiratoire infecties?
Authors: E Willems, Katrien Lagrou
Pages: 776 - 782